PITTSBURGH, Pennsylvania and CHESTER SPRINGS, Pennsylvania – June 25, 2019 — Compassionate Certification Centers™, a medical cannabis healthcare network, in collaboration with Affinity Bio Partners, a Clinical Research Organization (CRO) and AI Health Outcomes, CannaBot™, is pleased to announce the initiation of a medical marijuana focused observational study in Pennsylvania. The goal of this retrospective observational electronic study will be to gather data and measure medical marijuana patient reported outcomes from the Pennsylvania Medical Marijuana Program. This patient focused study will help provide valuable data and patient centered insights into the Pennsylvania Medical Marijuana Program, from initiation to current day.
“The data collected through this collaborative effort will provide tremendously valuable information about the medical cannabis program in Pennsylvania, in particular from a patient perspective.”, stated Dr. Bryan Doner, Compassionate Certification Centers co-founder and Chief Medical Officer. Dr Doner added “We hope this data and analysis can be used to better Pennsylvania’s medical marijuana program moving forward while at the same time providing a platform for similar projects in the future.”
Headquartered in Pittsburgh, Compassionate Certification Centers has 11 medical cannabis offices throughout the state of Pennsylvania. The Medical Cannabis Health Network provides evaluations and continued treatment services for patients. Compassionate Certification Centers recently launched its own line of THC-FREE™ CBD products, available to patients and non-cardholders.
“Compassionate Certification Centers’ focus on clinical research and vision for a more inclusive healthcare system aligns with our own.,” stated Christina DiArcangelo Puller, CEO, Affinity Bio Partners and AI Health Outcomes. CannaBot™. “Together, we will be able to see how the patients are doing within the Pennsylvania Medical Marijuana program. We look forward to collecting the patients’ responses to the specific questions via the CannaBot™.”
DiArcangelo Puller, alongside Dr. Bryan Doner, are slated to participate in upcoming World Cannabis CBD Awards in Barcelona, Spain July 17th to 19th 2019. For more information visit cccregister.com.
About Affinity Bio Partners and AI Health Outcomes (CannaBot™)
Affinity Bio Partners is a Clinical Research Organization (CRO) that provides best in class services while maintaining a personal approach. There are many CROs in the market, but there is only one that will give our client’s organization the attention, services and results. For more information on the company or general inquiries, please email: firstname.lastname@example.org or visit us at www.affinitybiopartners.com. Follow us on twitter at AffinityBioP, Facebook, LinkedIn and Instagram. AI Health Outcomes is an artificial intelligence technology company that has developed the first AI Bots; CannaBot™, DrBot™, a Learning Management System and an AI Patient Recruitment tool to assist with clinical research enrollment. For more information, please email: email@example.com or visit us at www.aihealthoutcomes.com, Facebook at CannaBot, Twitter at BotCanna, Linkedin and Instagram at @Cannabot.
About Compassionate Certification Centers
Compassionate Certification Centers is the first U.S. Medical Cannabis Healthcare System, specializing in cannabis medicine. The company is devoted to assisting U.S. citizens with discovering cannabis-derived treatment options for a wide-range of medical conditions. Compassionate Certification Centers’ network of convenient healthcare centers operate throughout some of the top U.S. medical regions providing Medical Marijuana consultations, THC & CBD treatment plans, and High-Quality CBD products. Recently, the company has announced their participation in efforts to further expand medical cannabis education and clinical research.